SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 53 filers reported holding SQZ BIOTECHNOLOGIES CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $8,680 | -77.2% | 15,500 | -8.2% | 0.00% | – |
Q3 2022 | $38,000 | -81.1% | 16,891 | -73.3% | 0.00% | – |
Q2 2022 | $201,000 | +44.6% | 63,241 | +118.0% | 0.00% | – |
Q1 2022 | $139,000 | +31.1% | 29,013 | +145.0% | 0.00% | – |
Q4 2021 | $106,000 | -35.4% | 11,844 | +3.9% | 0.00% | – |
Q3 2021 | $164,000 | – | 11,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRIDGER MANAGEMENT, LLC | 807,827 | $23,411,000 | 1.79% |
Alphabet Inc. | 831,389 | $24,094,000 | 1.16% |
Artal Group S.A. | 1,606,308 | $46,551,000 | 1.00% |
683 Capital Management, LLC | 466,176 | $13,510,000 | 0.64% |
MAVERICK CAPITAL LTD | 935,971 | $27,124,000 | 0.43% |
Temasek Holdings (Private) Ltd | 2,513,924 | $72,854,000 | 0.31% |
CAAS CAPITAL MANAGEMENT LP | 150,000 | $4,347,000 | 0.04% |
HRT FINANCIAL LP | 17,456 | $505,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 11,660 | $350,000 | 0.01% |
Hudock, Inc. | 350 | $10,000 | 0.00% |